Prescription medications can be a significant financial burden for many individuals, especially those without adequate insurance coverage. However, there is hope for those facing such challenges. Takeda Pharmaceuticals has developed the Help at Hand Program to assist patients in covering the cost of their prescription drugs. In this article, we will explore how this program has made a difference in the lives of patients and how you can benefit from it too.
How the patient assistance program works
The Help at Hand Program is a compassionate initiative by Takeda to provide financial assistance to patients who need help in paying for their Takeda prescription medications. It is designed to support individuals who may be facing financial hardships and are unable to afford the full cost of their prescribed drugs. By offering assistance, Takeda aims to ensure that patients can access the medications they need to manage their health conditions effectively.
Applying for the Takeda Patient Assistance Programs
To apply for The Help at Hand Program individuals need to complete a straightforward application form. Takeda Help at Hand Application (helpathandpap.com). The application process is free, and applicants only need to submit one application to be considered for multiple medications.
The application form will require applicants to provide personal and financial information. This information is necessary to determine eligibility based on income guidelines and residency requirements.
Once your application is submitted, the Takeda Patient Assistance Program will initiate the review process. It’s important to note that the review may take up to 3-5 business days. During this time, the program evaluates your application for completeness and eligibility.
To avoid processing delays, it is essential to submit a complete application. Incomplete applications may result in a request for additional information, further prolonging the review process. Therefore, it’s crucial to ensure that all the required documents and information are included with your application.
If your application meets the eligibility criteria, you will receive an approval letter from the Takeda Patient Assistance Program. This letter will inform you of how you will receive your prescribed medication through the program. Additionally, your healthcare provider will receive a similar approval letter via fax.
Once approved, the program’s pharmacy will ship the prescribed medication directly to the address provided on the application. This ensures that you receive the necessary medication conveniently and without any additional cost.
In some cases, certain information or documents may be missing or illegible in your application. If this occurs, both you and your healthcare provider will receive a notification letter either by fax or mail. It is crucial to respond promptly to these notifications to provide the missing information successfully.
Once the program receives the missing information, all the new documentation and details will be reviewed. However, if the program fails to reach you or your healthcare provider after three unsuccessful attempts, a denial decision may be made.
Denial and Appeals
If your application does not meet the eligibility criteria, you will receive a denial letter from the Takeda Patient Assistance Program. However, you have the option to appeal this decision within 90 days of the processing date. Alternatively, you can reapply after the 90 days, ensuring that your application meets the eligibility requirements.
During the appeal process, it is essential to provide any additional information or documentation that may strengthen your case. The program will review your appeal and make a final decision based on the provided information. It’s crucial to adhere to the appeal timeline and provide sufficient evidence to support your eligibility.
Re-enrollment in the Program
If your application is approved, the Takeda Patient Assistance Program offers assistance for up to one year. However, it’s important to note that you will need to re-apply in advance of your program eligibility end date if you continue to require assistance with your medication.
To ensure a seamless continuation of your medication coverage, the program will send you a reminder to renew your application before your enrollment ends. By re-enrolling in the program, you can continue to receive the necessary medication without interruption.
Eligibility criteria for the Patient Assistance Program
To be eligible for the Takeda Help at Hand Program, certain conditions must be met. Let’s take a closer look at these eligibility criteria:
Prescription by a U.S. Physician
To qualify for the Help at Hand Program, you must have been prescribed a Takeda medicine by a U.S. physician who is licensed and practicing in the United States or its territories. This requirement ensures that the program is available to individuals receiving medical care within the country.
Residence in the United States
You must currently be living in the United States or a U.S. territory to be eligible for the Help at Hand Program. Proof of citizenship is not required, but you must have a U.S. address. This criterion ensures that the program is accessible to those residing within the country.
Lack of Health Insurance Coverage or Financial Struggles
The Help at Hand Program aims to assist individuals who do not have adequate health insurance coverage or are facing financial difficulties in paying for their Takeda medicines. If you fall into either of these categories, you may be eligible for the program. This criterion ensures that those who need assistance the most can access the necessary medications.
Your annual household income needs to be equal to or less than a certain threshold to qualify for the Help at Hand Program. Have a household income equal to or less than 5 times the Federal Poverty Level (FPL) and vary depending on the size of your household. (for more information on Federal Poverty Levels, visit HHS Poverty Guidelines
Access to a wide range of medications
The Help at Hand Patient Assistance Program offers access to the following prescription medications:
- AMITIZA® (lubiprostone) Capsules
- CARBATROL® (carbamazepine) Extended-Release Capsules
- COLCRYS® (colchicine usp, USP) Tablets
- DEXILANT® (dexlansoprazole) Delayed Release Capsules
- FOSRENOL® (lanthanum carbonate) Chewable Tablets
- FOSRENOL® (lanthanum carbonate) Oral Powder
- INTUNIV® (guanfacine) Extended-Release Tablets
- KAZANO® (alogliptin and metformin HCI) Tablets
- LIALDA® (mesalamine) Delayed-Release Tablets
- MOTEGRITY® (prucalopride) Tablets
- NESINA® (alogliptin) Tablets
- OSENI® (alogliptin and pioglitazone) Tablets
- PENTASA® (mesalamine) Extended-Release Capsules
- PREVACID SOLUTAB® (lansoprazole) Delayed-Release Orally Disintegrating Tablets
- ROZEREM® (ramelteon) Tablets
- TRINTELLIX® (vortioxetine) Tablet
VYVANSE and MYDAYIS are no longer available through the Help at Hand Program. All applicants who enrolled prior to October 16, 2023, may receive medication until December 31, 2023. Please work with your healthcare provider to determine the appropriate next steps for your individual needs.
As part of the Takeda Patient Support Program, patients have access to a range of educational materials. These resources aim to provide valuable information and support to patients throughout their treatment journey. Whether it’s addressing questions and concerns or providing tools and resources, Takeda’s support specialists are dedicated to helping patients navigate their treatment plans.
The Takeda Patient Support Program offers several ways to assist patients, including:
- Working with specialty pharmacies or the designated site of care to facilitate the receipt of prescribed Takeda treatments
- Connecting patients to co-pay or insurance assistance programs to alleviate financial burdens
- Arranging nursing support for patients who have questions about their condition and the prescribed Takeda treatment
For more information on the Takeda Patient Support Program, visit the Takeda website.”
Other Takeda Patient Support Programs
In addition to the Takeda Patient Support Program, Takeda offers several other support programs at no cost to eligible patients. These programs are tailored to specific Takeda therapies and aim to provide personalized product support to patients and caregivers.
OnePath® is a program that offers personalized product support to patients and caregivers. This program is staffed by a dedicated team of specialists who provide assistance based on individual needs, medication requirements, or treatment access challenges. Depending on the specific circumstances, some OnePath team members are available for in-person meetings with patients, caregivers, and healthcare providers. To learn more about OnePath®, visit One Path.
Hematology Support Center (HSC)
For patients with bleeding disorders, the Hematology Support Center (HSC) provides dedicated support from a team of specialist healthcare professionals. Managing a bleeding disorder can be complex, but with the help of the HSC, patients and caregivers can receive the guidance and assistance they need. To learn more about the Hematology Support Center, visit Takeda Hematology Support Cente
EntyvioConnect is a program specifically designed to provide product support to patients who have been prescribed ENTYVIO® (vedolizumab) for injection. This program offers a range of services, including co-pay assistance, nurse support, and helpful tips to ensure a smooth treatment journey. To find out more about EntyvioConnect, visit EntyvioConnect .
The Help at Hand Program by Takeda is a lifeline for patients who struggle to afford their prescription medications. By providing financial assistance and support, Takeda aims to ensure that individuals can access the medications they need to lead healthier lives. The program’s eligibility criteria, assistance options, and additional resources make it a comprehensive solution for those in need. If you or someone you know requires assistance with the cost of Takeda prescription drugs, consider exploring the Help at Hand Program and take the first step toward a healthier and more affordable future.
NowPatient has taken all reasonable steps to ensure that all material is factually accurate, complete, and current. However, the knowledge and experience of a qualified healthcare professional should always be sought after instead of using the information in this page. Before taking any drug, you should always speak to your doctor or another qualified healthcare provider.
The information provided here about medications is subject to change and is not meant to include all uses, precautions, warnings, directions, drug interactions, allergic reactions, or negative effects. The absence of warnings or other information for a particular medication does not imply that the medication or medication combination is appropriate for all patients or for all possible purposes.
WHY WE BUILT NOWPATIENT
To improve the lives of everyone by making high-quality care accessible and convenient
We are here to improve lives. Our service gives you access to smart features and resources that can help empower you to take control of your health and improve your health outcomes. All this, in one place, for FREE. We strive to bring a fresh perspective to managing health. NowPatient can be accessed by downloading the App or using your web browser.
Download our app today
Can I trust NowPatient
Meet our medical review team
Trustworthy and reliable medical content authored and reviewed by our experienced team of medical professionals from the United Kingdom and the United States. Learn more about our team and our editorial process by clicking on the buttons below.